Norman A - Search Results

1

Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer.

Ross P, Nicolson M, Cunningham D, Valle J, Seymour M, Harper P, Price T, Anderson H, Iveson T, Hickish T, Lofts F, Norman A. Ross P, et al. Among authors: norman a. J Clin Oncol. 2002 Apr 15;20(8):1996-2004. doi: 10.1200/JCO.2002.08.105. J Clin Oncol. 2002. PMID: 11956258 Clinical Trial.

2

Impact of 5-fluorouracil rechallenge on subsequent response and survival in advanced colorectal cancer: pooled analysis from three consecutive randomized controlled trials.

Yeoh C, Chau I, Cunningham D, Norman AR, Hill M, Ross PJ. Yeoh C, et al. Clin Colorectal Cancer. 2003 Aug;3(2):102-7. doi: 10.3816/CCC.2003.n.016. Clin Colorectal Cancer. 2003. PMID: 12952566

3

Phase III study of mitomycin-C with protracted venous infusion or circadian-timed infusion of 5-fluorouracil in advanced colorectal carcinoma.

Price TJ, Ross PJ, Hickish T, Tait D, Norman AR, Ford HE, Middleton G, Sumpter K, Hill M, Oates J, Cunningham D. Price TJ, et al. Clin Colorectal Cancer. 2004 Feb;3(4):235-42. doi: 10.3816/CCC.2004.n.004. Clin Colorectal Cancer. 2004. PMID: 15025796 Clinical Trial.

4

Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data.

Chau I, Norman AR, Cunningham D, Waters JS, Oates J, Ross PJ. Chau I, et al. J Clin Oncol. 2004 Jun 15;22(12):2395-403. doi: 10.1200/JCO.2004.08.154. J Clin Oncol. 2004. PMID: 15197201 Clinical Trial.

5

Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin in inoperable pancreatic cancer.

Maisey N, Chau I, Cunningham D, Norman A, Seymour M, Hickish T, Iveson T, O'Brien M, Tebbutt N, Harrington A, Hill M. Maisey N, et al. Among authors: norman a. J Clin Oncol. 2002 Jul 15;20(14):3130-6. doi: 10.1200/JCO.2002.09.029. J Clin Oncol. 2002. PMID: 12118027 Clinical Trial.

6

Longitudinal quality of life and quality adjusted survival in a randomised controlled trial comparing six months of bolus fluorouracil/leucovorin vs. twelve weeks of protracted venous infusion fluorouracil as adjuvant chemotherapy for colorectal cancer.

Chau I, Norman AR, Cunningham D, Iveson T, Hill M, Hickish T, Lofts F, Jodrell D, Webb A, Tait D, Ross PJ, Shellito P, Oates JR. Chau I, et al. Among authors: norman ar. Eur J Cancer. 2005 Jul;41(11):1551-9. doi: 10.1016/j.ejca.2005.01.027. Eur J Cancer. 2005. PMID: 16026692 Clinical Trial.

7

Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.

Chau I, Brown G, Cunningham D, Tait D, Wotherspoon A, Norman AR, Tebbutt N, Hill M, Ross PJ, Massey A, Oates J. Chau I, et al. Among authors: norman ar. J Clin Oncol. 2006 Feb 1;24(4):668-74. doi: 10.1200/JCO.2005.04.4875. J Clin Oncol. 2006. PMID: 16446339 Clinical Trial.

8

A randomized trial comparing defined-duration with continuous irinotecan until disease progression in fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer.

Lal R, Dickson J, Cunningham D, Chau I, Norman AR, Ross PJ, Topham C, Middleton G, Hill M, Oates J. Lal R, et al. J Clin Oncol. 2004 Aug 1;22(15):3023-31. doi: 10.1200/JCO.2004.01.005. J Clin Oncol. 2004. PMID: 15284252 Clinical Trial.

9

A randomised study of protracted venous infusion of 5-fluorouracil (5-FU) with or without bolus mitomycin C (MMC) in patients with carcinoma of unknown primary.

Assersohn L, Norman AR, Cunningham D, Iveson T, Seymour M, Hickish T, Massey A, Prior Y, Hill ME. Assersohn L, et al. Among authors: norman ar. Eur J Cancer. 2003 May;39(8):1121-8. doi: 10.1016/s0959-8049(03)00150-3. Eur J Cancer. 2003. PMID: 12736112 Clinical Trial.

10

Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer.

Saini A, Norman AR, Cunningham D, Chau I, Hill M, Tait D, Hickish T, Iveson T, Lofts F, Jodrell D, Ross PJ, Oates J. Saini A, et al. Among authors: norman ar. Br J Cancer. 2003 Jun 16;88(12):1859-65. doi: 10.1038/sj.bjc.6600995. Br J Cancer. 2003. PMID: 12799627 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,980 results

Search Page

Filters